218 related articles for article (PubMed ID: 16631442)
1. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
[TBL] [Abstract][Full Text] [Related]
2. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
[TBL] [Abstract][Full Text] [Related]
3. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
[TBL] [Abstract][Full Text] [Related]
4. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
[TBL] [Abstract][Full Text] [Related]
5. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
[TBL] [Abstract][Full Text] [Related]
6. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
[TBL] [Abstract][Full Text] [Related]
7. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure.
Onat A; Ayhan E; Hergenç G; Can G; Barlan MM
Metabolism; 2009 Jul; 58(7):963-70. PubMed ID: 19411085
[TBL] [Abstract][Full Text] [Related]
8. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
[TBL] [Abstract][Full Text] [Related]
9. Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?
Mertens I; Considine RV; Van der Planken M; Van Gaal LF
Eur J Endocrinol; 2006 Sep; 155(3):477-84. PubMed ID: 16914603
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
11. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
Ragab A; Abousamra NK; Higazy A; Saleh O
Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
[TBL] [Abstract][Full Text] [Related]
12. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.
Lord J; Thomas R; Fox B; Acharya U; Wilkin T
BJOG; 2006 Oct; 113(10):1203-9. PubMed ID: 16753044
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.
Mertens I; Van der Planken M; Corthouts B; Wauters M; Peiffer F; De Leeuw I; Van Gaal L
Horm Metab Res; 2001 Oct; 33(10):602-7. PubMed ID: 11607880
[TBL] [Abstract][Full Text] [Related]
14. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
[TBL] [Abstract][Full Text] [Related]
15. Regional body fat distribution and metabolic profile in postmenopausal women.
Piché ME; Lapointe A; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J; Lemieux S
Metabolism; 2008 Aug; 57(8):1101-7. PubMed ID: 18640388
[TBL] [Abstract][Full Text] [Related]
16. PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.
Mertens I; Lemieux I; Verrijken A; Després JP; Van Gaal LF
Diabetes Metab Res Rev; 2008 Feb; 24(2):141-7. PubMed ID: 17922472
[TBL] [Abstract][Full Text] [Related]
17. Correlation between omental TNF-alpha protein and plasma PAI-1 in obesity subjects.
Cao YL; Wang YX; Wang DF; Meng X; Zhang J
Int J Cardiol; 2008 Aug; 128(3):399-405. PubMed ID: 17698217
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity.
Darmon P; Dadoun F; Boullu-Ciocca S; Grino M; Alessi MC; Dutour A
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E995-E1002. PubMed ID: 16772320
[TBL] [Abstract][Full Text] [Related]
19. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women.
De Pergola G; Ciampolillo A; Paolotti S; Trerotoli P; Giorgino R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):265-9. PubMed ID: 17547687
[TBL] [Abstract][Full Text] [Related]
20. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.
Caballero AE; Bousquet-Santos K; Robles-Osorio L; Montagnani V; Soodini G; Porramatikul S; Hamdy O; Nobrega AC; Horton ES
Diabetes Care; 2008 Mar; 31(3):576-82. PubMed ID: 18083792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
